Market Outlook

By 2035, the U.S. Ophthalmic Imaging Devices Market is projected to reach approximately USD 2.75 billion, expanding at a CAGR of 10.87% during 2026–2035. The market is estimated at USD 0.98 billion in 2025, with historical analysis covering 2021–2024. All market values in this report are expressed in USD billions.

The historical market expanded from approximately USD 0.67 billion in 2021 to USD 0.89 billion in 2024, reflecting recovery in ophthalmology procedure volumes, replacement of aging diagnostic platforms, wider installation of optical coherence tomography systems, increased retinal imaging in optometry, and growing use of digital imaging for diabetes-related eye screening. The market reached approximately USD 0.73 billion in 2022 and USD 0.80 billion in 2023 before advancing to USD 0.98 billion in 2025.

The U.S. ophthalmic imaging devices industry is moving from a collection of stand-alone diagnostic instruments toward an integrated imaging ecosystem built around high-resolution OCT, OCT angiography, ultra-widefield retinal imaging, digital fundus photography, anterior-segment imaging, ocular ultrasound, automated image acquisition, AI-assisted interpretation, and cloud-enabled longitudinal disease management.

The market scope includes ophthalmic imaging systems, embedded imaging modules and directly associated image-analysis technologies used to acquire, visualize and analyze retinal, optic nerve, choroidal, corneal, anterior-segment and deeper ocular structures. The scope excludes broad ophthalmic categories such as intraocular lenses, surgical consumables, tonometers without imaging capabilities, basic visual-field testing, spectacles, contact lenses and pharmaceutical products.

Clinical economics are becoming as important as raw image resolution. U.S. ophthalmology practices and health systems increasingly evaluate whether a new platform can reduce acquisition time, limit repeat scans, automate alignment, facilitate technician delegation, consolidate several imaging modalities, improve referral conversion, support documentation and integrate historical images into the physician workflow.

The strongest value creation through 2035 is expected to occur around swept-source OCT, OCT angiography, multimodal retinal imaging, ultra-widefield imaging, AI-assisted disease detection, portable retinal imaging and image-data interoperability. These areas can increase diagnostic yield while addressing physician shortages, technician productivity requirements and growing volumes of chronic retinal disease surveillance.

 

Introduction

According to the U.S. Ophthalmic Imaging Devices Market Report, ophthalmic imaging has become a central clinical infrastructure layer across retina, glaucoma, corneal disease, diabetic eye care, cataract assessment and specialty ophthalmology. Modern eye care increasingly depends on objective image datasets rather than direct visualization alone, particularly where clinicians need to detect subtle structural change over multiple visits.

The addressable clinical burden is substantial. Approximately 9.6 million Americans were estimated to be living with diabetic retinopathy in 2021, including about 1.84 million with vision-threatening disease. Glaucoma affected approximately 4.2 million Americans in 2022, including nearly 1.5 million with vision-affecting glaucoma. Age-related macular degeneration affected approximately 19.8 million Americans aged 40 years and older in 2019, including around 1.49 million with vision-threatening AMD.

These conditions have one important commercial characteristic in common: diagnosis and management frequently require repeated imaging. A patient undergoing retinal treatment may receive serial OCT scans to evaluate macular fluid. A glaucoma patient may require longitudinal optic-nerve and retinal nerve fiber layer analysis. A diabetic patient may undergo fundus photography or OCT depending on disease stage. A patient with unexplained media opacity may require ultrasound. This recurring imaging requirement supports utilization well beyond the original capital-equipment purchase.

Demographics reinforce the demand outlook. The U.S. population aged 65 and older reached approximately 61.2 million in 2024 and represented about 18% of the population. Aging increases the incidence of AMD, glaucoma, cataract, retinal vascular disease and other disorders that frequently require imaging. The commercially relevant opportunity is therefore not simply population growth; it is growth in the number of people requiring repeated imaging over several years.

The U.S. market is differentiated from many international ophthalmic imaging markets by its extensive specialty-practice infrastructure. Large retina groups, comprehensive ophthalmology practices, academic eye centers, integrated delivery networks and multi-location optometry businesses can support premium capital purchases when those investments improve throughput and generate reimbursable diagnostic activity.

The competitive model is also changing. Historically, vendors competed primarily through image quality and physician preference. Buyers increasingly compare platforms according to acquisition speed, multimodal capability, field of view, automated positioning, diagnostic software, normative databases, interoperability, service support, cybersecurity, upgrade pathways and total ownership cost.

By 2035, successful ophthalmic imaging companies will increasingly be judged on whether they can create a longitudinal imaging environment rather than sell a single diagnostic box. Systems able to combine acquisition, comparison, interpretation, referral, documentation and analytics will influence procurement more strongly than isolated devices lacking workflow connectivity.

 

Key Market Drivers: What’s Fueling the U.S. Ophthalmic Imaging Devices Market Boom?

The first major driver is the expanding chronic retinal disease population. Diabetic retinopathy, AMD, retinal vein occlusion, diabetic macular edema, geographic atrophy and other retinal conditions require high-quality structural and vascular imaging. OCT has become fundamental to retinal decision-making because therapy frequently depends on evidence of fluid, retinal thickness changes, atrophy or treatment response.

Diabetic eye disease creates a particularly large screening opportunity. Millions of Americans live with diabetic retinopathy, yet a substantial percentage of patients with diabetes do not obtain annual eye examinations. This gap encourages imaging to move beyond ophthalmology offices into endocrinology, primary care, federally qualified health centers, retail health networks and teleophthalmology programs. Automated fundus cameras and AI-assisted interpretation can make this model economically feasible where specialist availability is limited.

A second driver is the high prevalence and underdiagnosis of glaucoma. Glaucoma can progress without noticeable early symptoms, increasing the importance of structural imaging before significant vision loss occurs. OCT-based analysis of the optic nerve head, retinal nerve fiber layer and ganglion cell complex has therefore become central to modern glaucoma evaluation. Because disease management is longitudinal, installed OCT systems generate repeated utilization over the patient lifecycle.

A third driver is population aging. More than 61 million Americans were aged 65 or older by 2024. This demographic carries substantially greater exposure to AMD, glaucoma, cataract, retinal vascular disease and multiple comorbid eye conditions. Florida is particularly important from a commercial perspective because its older population contributes to some of the country’s highest age-related eye-disease burden. Aging is also accelerating in Arizona, the Carolinas, Texas and several Mountain West markets, creating new imaging demand outside traditional academic ophthalmology centers.

The fourth driver is the transition from conventional photography to multimodal imaging. Ophthalmologists increasingly want structural, vascular, peripheral and functional information available from fewer patient encounters. A modern retina workflow may combine OCT, OCTA, autofluorescence, color imaging, fluorescein angiography, indocyanine green imaging and ultra-widefield imaging. This creates demand for platforms that consolidate multiple modalities and reduce the need to move a patient between diagnostic rooms.

A fifth driver is higher emphasis on technician productivity and clinic throughput. Specialty ophthalmology practices frequently operate under workforce constraints. Automated alignment, autofocus, auto-capture, motion correction and simplified acquisition allow technicians to image more patients with less operator variability. Procurement committees therefore increasingly measure the number of diagnostic workups completed per room and per technician rather than evaluating equipment solely on acquisition price.

A sixth driver is the migration of retinal screening toward primary care and distributed settings. Digital fundus cameras are becoming easier for non-ophthalmic staff to operate. Combined with cloud transmission and autonomous or assistive AI, imaging can be performed closer to where patients with diabetes already receive routine care. This reduces dependence on separate specialist appointments and creates a new addressable market for compact, automated and portable cameras.

A seventh driver is reimbursement and quality-measure alignment. Retinal examinations are incorporated into diabetes care-quality frameworks, while OCT, fundus photography and related ophthalmic diagnostic procedures are established within U.S. specialty-care reimbursement pathways when medically necessary. Medicare is especially important because older beneficiaries account for a disproportionate share of AMD, glaucoma and retinal disease utilization.

The economics of untreated vision disease further support early imaging. Vision loss and blindness create substantial direct medical, supportive-care and productivity costs. For payers and integrated health systems, identifying treatable disease before irreversible deterioration can therefore carry economic value beyond the ophthalmology department.

An eighth driver is capital replacement and installed-base modernization. Many established U.S. eye practices already own OCT and retinal cameras, meaning future growth will not depend entirely on first-time adoption. Instead, vendors can monetize replacement cycles by offering faster scan speeds, wider fields, improved depth penetration, OCT angiography, automated segmentation, multimodal capture and stronger software integration. Premium replacement is likely to become one of the market’s most important revenue pools.

A ninth driver is growth in retina-focused pharmaceutical treatment. The expanding number of therapies targeting neovascular AMD, diabetic macular edema, geographic atrophy and retinal vascular disease increases the importance of imaging-based patient selection and follow-up. As retinal therapies become more differentiated, imaging can help determine disease phenotype, treatment timing and response, giving high-resolution platforms additional strategic value.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in U.S. ophthalmic imaging is increasingly directed toward seeing more anatomy, collecting more information per encounter and reducing the manual work required to obtain diagnostically useful images.

Swept-source OCT is one of the most significant technology transitions. Longer-wavelength light and faster acquisition can improve penetration through ocular structures and enable wider or deeper scans. Vendors are using swept-source architectures to support retinal imaging, choroidal visualization, widefield OCT, anterior-segment applications and multimodal platforms.

OCT angiography is expanding the value of conventional OCT by providing non-invasive visualization of retinal and choroidal microvasculature. Although dye-based angiography remains clinically important, OCTA can provide additional vascular information without intravenous contrast. Its role is becoming more prominent in retina, glaucoma research and longitudinal vascular assessment.

Ultra-widefield imaging is another strategic growth category. Conventional fundus photography captures a smaller portion of the retina in a single frame, while advanced UWF systems can document substantially more peripheral retina. This is valuable in diabetic retinopathy, retinal tears, vascular disorders, inflammatory disease and peripheral pathology where clinically meaningful lesions may occur outside the traditional posterior-pole field.

Multimodal consolidation is raising capital value per installation. Platforms increasingly combine color imaging, autofluorescence, scanning laser ophthalmoscopy, OCT, OCTA and angiographic capabilities. Consolidation can improve room utilization, reduce patient movement, facilitate side-by-side interpretation and lower the workflow friction associated with maintaining several independent devices.

Artificial intelligence is becoming an important commercial layer. Autonomous diabetic retinopathy systems have demonstrated that retinal imaging can support disease detection outside traditional eye-care settings. Within specialty care, AI is increasingly positioned as an assistive tool for image quality assessment, segmentation, progression analysis, lesion identification, workflow prioritization and quantitative measurement.

AI-enabled imaging remains a relatively small portion of current hardware revenue but has a substantially higher growth profile than traditional imaging equipment. Its commercial importance is greater than its direct revenue share because AI can influence camera selection, data-management architecture and health-system deployment strategy.

Automation is another major innovation front. Auto-alignment, auto-focus, automatic scan placement, robotic camera operation and quality-control software enable more diagnostic tasks to be delegated. For multi-site ophthalmology groups, consistent image acquisition across technicians and facilities is increasingly important because inconsistent scans reduce the value of longitudinal comparison.

Interoperability is also becoming a competitive differentiator. Eye-care groups frequently operate mixed fleets containing devices from several manufacturers. Vendor-neutral image management, DICOM compatibility, EHR integration and cloud-based referral workflows can reduce data fragmentation. Companies controlling the imaging-data layer can potentially strengthen customer retention even when the installed hardware base is heterogeneous.

Portable and handheld imaging is expanding the market beyond conventional diagnostic rooms. Compact fundus cameras can support diabetes screening, pediatric examinations, home-health initiatives, mobile clinics and rural programs. Portable OCT is also relevant where patients cannot easily position at conventional tabletop equipment.

The next innovation cycle will increasingly focus on oculomics, using ocular imaging as a potential source of systemic health information. The retina provides direct visualization of neural and vascular structures, creating research opportunities in cardiovascular, metabolic and neurologic disease. While many oculomics applications remain investigational, the trend increases the strategic value of large standardized ophthalmic image datasets.

 

Segmentation Insights

The U.S. Ophthalmic Imaging Devices Market is segmented on the basis of product category, application, end user, technology type and region.

 

By Product Category

Optical Coherence Tomography and OCT Angiography Systems

OCT/OCTA represents the largest product category and accounts for an estimated USD 0.43 billion of the 2025 market, or roughly 44% of market value. Its leadership reflects widespread use in retina and glaucoma as well as expansion into anterior-segment imaging. Premium systems are moving toward faster acquisition, swept-source architectures, wider scans, OCTA and advanced progression analytics.

OCT is also the strongest contributor to replacement-cycle economics. Clinics with established spectral-domain installations have a reason to upgrade when new platforms deliver measurable workflow or diagnostic advantages. This makes OCT a more attractive long-term value pool than imaging categories dependent primarily on first-time installation.

Fundus Cameras and Digital Retinal Imaging Systems

Fundus cameras represent an estimated USD 0.18 billion in 2025. Demand includes conventional ophthalmology, optometry, diabetes screening and teleophthalmology. Non-mydriatic cameras are especially important because they reduce workflow friction and can often obtain usable images without routine pharmacologic dilation.

This segment is becoming more automated and less dependent on highly trained operators. Robotic positioning, smaller-pupil imaging, automatic exposure selection and cloud connectivity are widening the potential user base. Growth is expected to remain below advanced OCT but stable because retinal photography is fundamental to screening, documentation and longitudinal disease comparison.

Ultra-Widefield Retinal Imaging Systems

Ultra-widefield imaging represents approximately USD 0.12 billion in the 2025 market and is among the faster-growing premium categories. Adoption is strongest in retina practices, tertiary eye centers and comprehensive ophthalmology groups seeking to improve peripheral retinal visualization.

Clinical value is especially compelling in diabetic retinopathy, retinal breaks, vascular disease and inflammatory conditions. Integrated UWF-plus-OCT platforms may accelerate growth because practices can consolidate structural and peripheral imaging into one workflow.

Ophthalmic Ultrasound and Biometry Imaging Systems

Ophthalmic ultrasound and related imaging systems account for approximately USD 0.11 billion in 2025 within the defined imaging scope. B-scan ultrasound remains clinically important when direct optical visualization is limited by dense cataract, vitreous hemorrhage or other media opacity. Ultrasound biomicroscopy supports evaluation of anterior structures that can be difficult to assess with conventional techniques.

This is a more mature market than OCT, but demand remains durable because the modality solves diagnostic problems that optical imaging cannot fully replace.

Corneal, Anterior-Segment and Specialty Imaging Systems

Corneal tomography, topography, specular microscopy, anterior-segment OCT and digitally enabled slit-lamp imaging together represent approximately USD 0.14 billion in 2025. Demand is tied to corneal disease, refractive surgery, cataract evaluation, contact-lens assessment and surgical planning.

Premium growth will concentrate in systems that combine multiple anterior-segment measurements and reduce the need for separate diagnostic platforms. Integrated cataract and refractive practices are particularly attractive customers because diagnostic efficiency directly influences surgical throughput.

 

By Application

Retinal Disorders

Retinal diseases constitute the largest application segment, accounting for approximately 43% of the 2025 market, equivalent to roughly USD 0.42 billion. Major conditions include AMD, diabetic retinopathy, diabetic macular edema, retinal vein occlusion, retinal tears and detachments, inherited retinal disease and inflammatory disorders.

Retina is the most imaging-intensive ophthalmic specialty because clinical management frequently depends on serial comparison. Treatment decisions for anti-VEGF therapy, geographic atrophy and diabetic macular edema can require repeated OCT and multimodal imaging, making this application structurally attractive.

Glaucoma

Glaucoma represents approximately 22% of market demand, or around USD 0.22 billion in 2025. Structural imaging of the optic nerve and retinal nerve fiber layer is now deeply embedded in glaucoma evaluation and follow-up.

With more than four million Americans estimated to have glaucoma and a significant portion of disease remaining undiagnosed, the opportunity extends from specialist management to improved case finding. Progression analysis and normative databases are key competitive features because the principal clinical challenge is identifying meaningful structural change over time.

Cataract and Preoperative Ocular Assessment

Cataract-related and preoperative imaging represents approximately 14% of the 2025 market. While cataract itself is often diagnosed clinically, imaging is increasingly used to identify macular or corneal disease that may alter surgical planning, expected visual outcome or premium-IOL selection.

High-volume cataract practices increasingly value integrated diagnostics that allow the surgeon to identify retinal pathology before surgery and reduce postoperative dissatisfaction caused by previously undetected disease.

Corneal and Refractive Disorders

Corneal and refractive applications account for approximately 12% of the market. Corneal topography, tomography, pachymetric imaging and anterior-segment OCT are used for keratoconus detection, refractive surgery screening, corneal transplant evaluation and specialty contact-lens fitting.

Growth is linked less to population-scale chronic disease than to premium procedural workflows, meaning vendors compete strongly on measurement reproducibility, software analytics and integration with surgical planning systems.

Other Ophthalmic Applications

The remaining market includes uveitis, neuro-ophthalmology, pediatric retinal disease, ocular tumors, inherited retinal disorders, trauma and research imaging. Although individually smaller, these applications are strategically important in academic medical centers where advanced multimodal systems support clinical trials and subspecialty care.

 

By End User

Ophthalmology Specialty Clinics and Group Practices

Specialty ophthalmology practices are the largest end-user category and account for approximately 48% of 2025 market revenue, or about USD 0.47 billion. Retina, glaucoma and comprehensive ophthalmology groups frequently operate several imaging rooms and replace equipment on structured capital cycles.

Large multi-site practices increasingly centralize procurement and standardize platforms across locations. Vendors capable of offering enterprise pricing, remote service, image management and standardized technician training have an advantage in this environment.

Hospitals and Academic Eye Centers

Hospitals and academic ophthalmology centers represent approximately 22% of market demand. These institutions are important early adopters of advanced multimodal imaging, research-grade OCT, angiography and specialized imaging platforms.

Although their unit volumes may be lower than large private-practice networks, academic centers influence physician training, clinical research and technology diffusion. Their procurement process is typically more evidence-driven and may involve IT, cybersecurity, research and enterprise-integration review.

Optometry Practices and Retail Eye-Care Networks

Optometry represents approximately 15% of 2025 revenue and is strategically important because it expands advanced imaging into routine eye care. OCT, fundus photography and widefield imaging are increasingly used for early detection and referral.

Automation is particularly valuable in this setting because imaging must fit high-throughput examination workflows. Systems that are compact, simple to operate and capable of producing patient-friendly visual outputs have an advantage.

Ambulatory Surgery Centers

ASCs account for approximately 8% of market value. Their imaging demand centers on preoperative cataract assessment, corneal evaluation, biometry-adjacent imaging and selected retinal diagnostics.

ASC purchasing is strongly influenced by procedure throughput and space efficiency. Multifunction platforms are attractive where they can reduce the number of diagnostic instruments required per surgical facility.

Primary Care, Teleophthalmology and Distributed Screening Networks

Primary-care and distributed screening settings represent approximately 7% of the current market but are expected to record one of the strongest growth rates. The primary use case is diabetic retinal imaging integrated with automated interpretation or remote specialist review.

The commercial opportunity is substantial because screening can be performed wherever patients with diabetes already receive care. Vendors must, however, solve workflow integration, image-quality management, referral closure and reimbursement—not merely supply a camera.

 

By Technology Type

Spectral-Domain OCT

Spectral-domain OCT remains the largest imaging-technology segment, accounting for approximately one-third of 2025 market value. Its installed base is extensive and the technology offers a strong balance of scan speed, resolution and cost.

The principal strategic issue is replacement. Vendors must demonstrate a meaningful improvement in workflow, image quality, analytics or multimodal integration to convince mature practices to replace functioning equipment.

Swept-Source OCT and OCT Angiography

Swept-source OCT and OCTA together represent a smaller but rapidly expanding technology pool. They are expected to capture a disproportionately large share of incremental market revenue through 2035 as practices seek faster, wider and deeper imaging.

Premium pricing can be sustained where improvements translate into better visualization, reduced scan time or expanded clinical applications.

Scanning Laser Ophthalmoscopy and Ultra-Widefield Imaging

Scanning laser and UWF technologies represent a major premium retinal-imaging category. Their ability to visualize peripheral pathology differentiates them from conventional fundus photography.

Multimodal platforms integrating scanning laser imaging with OCT are likely to gain share because they can reduce equipment fragmentation in high-volume retina environments.

Digital Color, Autofluorescence and Angiographic Imaging

Digital color photography remains fundamental to clinical documentation and diabetic screening. Fundus autofluorescence provides additional information in retinal degenerative disease, while fluorescein and indocyanine green angiography remain important for selected retinal and choroidal vascular conditions.

The opportunity increasingly lies in integrating these modalities into a common image-management environment rather than treating them as independent tests.

Ultrasound and Anterior-Segment Optical Imaging

Ultrasound, ultrasound biomicroscopy, corneal tomography, topography, specular microscopy and anterior-segment OCT form a diverse technology category serving conditions not fully addressed by posterior-segment optical imaging.

Growth is expected to be moderate but durable, with the strongest pricing power in systems offering multimodal measurements and surgical-planning integration.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. Ophthalmic Imaging Devices Market is geographically segmented into the South, West, Northeast and Midwest. Regional demand varies according to aging demographics, diabetes prevalence, ophthalmologist concentration, health-system investment, academic-eye-center density, population migration, payer mix and adoption of advanced specialty care.

The South is estimated to be the largest regional market in 2025 at approximately USD 0.32 billion, while the West is expected to record the fastest growth through 2035. The Northeast remains a high-value innovation and academic-care market, while the Midwest provides a stable installed base of ophthalmology and optometry demand.

South

The South represents an estimated USD 0.32 billion in 2025 and is projected to approach USD 0.93 billion by 2035, representing an approximate regional CAGR of 11.3%. Population growth, aging, diabetes burden and expansion of large ophthalmology groups make the region the most important market by total revenue.

For this report, the Southern market includes Alabama, Arkansas, Delaware, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, West Virginia and the District of Columbia.

Florida is one of the country’s most commercially attractive ophthalmic imaging markets because of its large elderly population. State-level modeled data have placed crude AMD prevalence as high as approximately 18.3%, among the highest in the country. This creates strong demand for OCT, OCTA, fundus photography and multimodal retina platforms across Miami, Tampa, Orlando, Jacksonville, Fort Lauderdale and retirement-heavy coastal markets.

Texas provides a different growth profile. Its attractiveness comes from population scale, major metropolitan expansion and extensive ophthalmology infrastructure in Houston, Dallas-Fort Worth, Austin and San Antonio. Diabetes and uneven specialist access in rural parts of the state increase the potential for distributed retinal screening in addition to premium imaging at tertiary centers.

North Carolina is becoming strategically important through rapid population growth around Charlotte, Raleigh-Durham and the Triad. The state combines major academic medical centers with expanding community ophthalmology groups, creating demand ranging from research-grade multimodal imaging to automated private-practice OCT.

Georgia and Tennessee show similar dynamics. Atlanta, Nashville and other metropolitan markets support advanced retina and glaucoma care, while large rural populations create unmet screening needs. Compact retinal cameras and teleophthalmology platforms can therefore complement premium specialist equipment.

Virginia and Maryland benefit from dense healthcare infrastructure around Washington, D.C., Baltimore, Richmond and Northern Virginia. High specialist concentration, academic centers and technology-oriented health systems make these markets receptive to integrated imaging software and advanced diagnostic platforms.

Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma and West Virginia represent smaller equipment markets but have substantial chronic-disease burden and rural-access challenges. The commercial opportunity is increasingly tied to lower-footprint imaging, regional referral networks and diabetes screening rather than exclusive dependence on tertiary ophthalmology centers.

The South’s long-term advantage is the combination of population growth and disease burden. It is therefore expected to remain the largest U.S. ophthalmic imaging region through 2035.

West

The West represented approximately USD 0.25 billion in 2025 and is projected to reach roughly USD 0.81 billion by 2035, equating to an estimated CAGR of about 12.5%, the fastest among the four regions.

The Western region includes Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington and Wyoming.

California is the largest state market in the West. Its nearly 40 million residents, sophisticated academic eye centers, extensive managed-care infrastructure and concentration of technology companies make it an important early-adoption environment. The state is particularly relevant for AI-enabled retinal screening, multimodal OCT, advanced image analytics and large-scale image-data programs.

California’s older population exceeds six million residents aged 65+, creating an important base for AMD, glaucoma and cataract-related imaging. Los Angeles, San Francisco, San Diego, Sacramento and Orange County support substantial premium ophthalmology demand.

Arizona is one of the most attractive growth states because population growth and retirement migration increase exposure to age-related eye disease. Phoenix and Tucson are expanding specialty-care hubs, supporting demand for retina, glaucoma and cataract diagnostics.

Nevada also benefits from migration and population growth, although disease prevalence can vary substantially by condition. Las Vegas and Reno are the principal imaging markets. The state is attractive for automated and high-throughput equipment because rapidly growing practices must expand capacity alongside population.

Washington and Oregon have sophisticated integrated delivery networks and strong digital-health adoption. These markets are particularly relevant for enterprise image management, interoperability and AI-assisted clinical workflow.

Colorado and Utah combine fast-growing metropolitan populations with strong healthcare systems and research-oriented provider networks. Denver, Salt Lake City and surrounding markets are favorable for premium OCT and comprehensive ophthalmic diagnostic platforms.

New Mexico, Idaho, Montana, Wyoming and Alaska have lower absolute capital-equipment volumes but present a strong use case for distributed imaging because of geographic distance and specialist-access limitations. Portable fundus cameras, cloud-enabled interpretation and teleophthalmology can therefore play a larger role than their population size alone would imply.

Hawaii represents a geographically distinct ophthalmic market in which remote specialist access and diabetes screening are particularly relevant.

The West’s fastest-growth position is supported by technology adoption, migration, AI readiness and expanding use of imaging outside traditional specialty offices.

Northeast

The Northeast represented an estimated USD 0.24 billion in 2025 and is projected to reach approximately USD 0.60 billion by 2035, corresponding to an estimated CAGR of about 9.6%.

The region includes Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island and Vermont.

New York is the region’s largest state market. New York City contains a dense concentration of ophthalmology groups, academic centers and subspecialty practices, while upstate markets support significant community ophthalmology demand. Premium OCT, ultra-widefield imaging and multimodal retina systems have strong penetration.

Massachusetts is strategically influential despite its smaller population. State-level diabetic-retinopathy estimates have historically shown a comparatively high prevalence among people with diabetes, and the Boston healthcare ecosystem contains major academic institutions and research programs. Manufacturers frequently view these institutions as important sites for clinical validation, advanced imaging research and physician education.

Pennsylvania represents a substantial commercial market through Philadelphia, Pittsburgh and regional health networks. The state has meaningful elderly and chronic-disease populations supporting retina and glaucoma imaging demand.

New Jersey combines high population density, specialist access and proximity to pharmaceutical and life-science companies. Retina imaging is particularly relevant to clinical-trial networks evaluating therapies for AMD, diabetic retinopathy and other retinal disorders.

Connecticut, Rhode Island, New Hampshire, Maine and Vermont are smaller markets by population but benefit from established specialist infrastructure. Aging demographics in several New England states support durable retinal and glaucoma imaging utilization.

The Northeast is unlikely to lead national volume growth because its population expansion is slower than the South and West. However, it will remain disproportionately influential for premium technology, research imaging, clinical trials and adoption of advanced diagnostic protocols.

Midwest

The Midwest accounted for approximately USD 0.17 billion in 2025 and is projected to reach approximately USD 0.41 billion by 2035, reflecting an estimated CAGR near 9.2%.

The region includes Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota and Wisconsin.

Illinois is the region’s largest metropolitan imaging market, driven by Chicago’s academic hospitals, specialty eye centers, multi-location ophthalmology practices and large optometry network.

Ohio has a strong ophthalmic-care infrastructure across Cleveland, Columbus and Cincinnati. High-volume hospitals and specialty groups support a broad installed base of OCT, fundus and corneal imaging systems.

Michigan combines large metropolitan demand with significant diabetes and chronic-disease burden. Detroit, Ann Arbor and Grand Rapids represent the major ophthalmic equipment markets.

Minnesota is strategically important because of its advanced medical-technology ecosystem and large integrated provider organizations. It is an attractive market for enterprise-level imaging standardization and connected diagnostics.

Wisconsin, Indiana and Missouri provide stable procedure and diagnostic volumes through established community and academic networks. Vendors tend to compete effectively when they combine reliable service coverage with strong capital pricing.

Iowa, Kansas and Nebraska are smaller but stable markets where regional referral systems support centralized specialty imaging.

North Dakota and South Dakota have lower absolute equipment volumes but demonstrate the importance of teleophthalmology, remote image interpretation and hub-and-spoke specialty care.

The Midwest is expected to remain the most stable rather than the fastest-growing region. Replacement cycles, service quality and total ownership economics will be particularly important competitive factors.

 

Key Market Players

The U.S. Ophthalmic Imaging Devices competitive landscape is moderately consolidated at the premium hardware level but increasingly fragmented across AI, software and distributed retinal screening.

Major manufacturers compete on OCT performance, scan speed, field of view, multimodal capability, automation, image analytics, normative databases, cybersecurity, enterprise integration, physician familiarity and installed-base service.

Some of the key companies active within or directly relevant to the U.S. ophthalmic imaging ecosystem include Carl Zeiss Meditec AG; Topcon Healthcare; Heidelberg Engineering GmbH; Optos plc/Nikon; NIDEK Co., Ltd.; Canon Inc./Canon U.S.A.; Haag-Streit Group; OCULUS Optikgeräte GmbH; Visionix/Optovue; Revenio Group/iCare; Kowa Company Ltd.; Tomey Corporation; Lumibird Medical/Quantel Medical; DGH Technology, Inc.; Escalon Medical/Sonomed; Baxter/Hillrom-Welch Allyn; Optomed Plc; Phoenix Technology Group; Digital Diagnostics, Inc.; Eyenuk, Inc.; AEYE Health; RetinAI Medical AG; Alcon; and Ziemer Ophthalmic Systems.

ZEISS, Topcon, Heidelberg Engineering and Optos occupy particularly influential positions in advanced retinal and OCT imaging. Their strength comes from installed bases, physician familiarity, premium imaging platforms and the ability to connect hardware with analysis software and longitudinal patient data.

NIDEK, Visionix/Optovue, iCare/CenterVue, OCULUS, Tomey and Haag-Streit compete across retinal, OCT, corneal and comprehensive diagnostic workflows. Their opportunities are strongest where practices seek multifunction systems, compact equipment or alternatives to the largest premium vendors.

AI-focused companies such as Digital Diagnostics, Eyenuk and AEYE Health are changing the competitive boundary of the market. Their strategic significance comes from moving retinal imaging into settings where an ophthalmologist may not be physically present.

Optomed and other portable-camera vendors compete for screening programs, primary-care deployments and mobile workflows. This category could become materially larger if health systems adopt retinal imaging as a routine diabetes-care intervention.

Competition through 2035 will increasingly be platform-based rather than instrument-based. A vendor capable of integrating OCT, photography, UWF imaging, analytics, image management and referral workflows can exert more influence on future purchasing than a vendor offering only superior hardware.

Hospital and multi-site group contracts will also become more strategic. Enterprise buyers may favor standardized equipment fleets because common training, image management and service agreements reduce operating complexity.

 

Recent Developments

Recent developments in the U.S. Ophthalmic Imaging Devices Market demonstrate that the innovation cycle is shifting toward automated acquisition, integrated multimodal imaging, autonomous AI and connected image-management ecosystems.

In April 2024, AEYE Health received U.S. FDA 510(k) clearance for an AEYE-DS diabetic-retinopathy detection configuration. Autonomous diabetic retinal screening is strategically important because it moves part of the diagnostic workflow into primary-care environments and reduces dependence on immediate specialist interpretation.

In February 2025, Optos introduced MonacoPro, combining ultra-widefield scanning laser imaging with spectral-domain OCT capabilities and enhanced automation. The platform reflects a wider market shift toward acquiring several clinically useful image types from one diagnostic station.

In April 2025, the U.S. FDA provided 510(k) clearance for the ZEISS CLARUS 700, reinforcing competition in high-resolution, widefield retinal imaging. Advanced retinal cameras are increasingly differentiated by image quality, color fidelity, peripheral visualization, multimodal capability and integration with existing ophthalmic image databases.

In May 2025, Heidelberg Engineering received U.S. FDA clearance for updated SPECTRALIS HRA+OCT variants. Continued regulatory activity around established imaging platforms shows that innovation within mature installed bases remains commercially important; manufacturers can create replacement demand through improved software, scanning functionality and imaging modules.

In July 2025, Topcon Healthcare acquired Intelligent Retinal Imaging Systems, strengthening its presence in cloud-based retinal screening and connected care. This development illustrates the convergence of imaging equipment, primary-care screening, EMR connectivity and AI-assisted diagnostic workflows.

In October 2025, Optos introduced Silverstone RGB, integrating 200-degree single-shot retinal imaging, multiple retinal imaging modalities and swept-source OCT. The direction of development is commercially significant because practices increasingly seek to reduce the number of separate systems required for comprehensive retina diagnostics.

During 2025, Topcon also expanded the capabilities of its Maestro2 platform around OCTA and high-resolution imaging, emphasizing workflow improvements and advanced retinal analytics.

In June 2026, the U.S. FDA cleared Topcon’s Harmony Referral System with Harmony OCT Viewer. Although image-management software represents a different revenue category from capital imaging equipment, the clearance illustrates a central strategic trend: ophthalmic imaging competition is increasingly extending from image acquisition into referral, viewing and data-management workflow.

These developments reinforce five major competitive themes for the forecast period: greater automation, wider-field imaging, increased use of swept-source OCT, AI integration and tighter connection between imaging hardware and enterprise clinical-data systems.

 

Conclusion

The U.S. Ophthalmic Imaging Devices Market Size & Share is positioned to increase from approximately USD 0.98 billion in 2025 to USD 2.75 billion by 2035, representing a 10.87% CAGR from 2026 through 2035.

This growth trajectory is supported by structural rather than transient factors. The United States has millions of patients living with diabetic retinopathy, AMD and glaucoma, more than 61 million residents aged 65 or older, extensive ophthalmology infrastructure and an established reimbursement environment for medically necessary diagnostic imaging.

The most important commercial change is the movement from isolated diagnostic instruments toward multimodal, automated and connected imaging platforms. OCT will remain the largest value pool, but future growth will increasingly come from swept-source technology, OCT angiography, ultra-widefield imaging, AI-enabled screening, longitudinal analytics and integrated image management.

Retinal disease will remain the largest application category because AMD, diabetic eye disease and retinal vascular conditions require repeated imaging. Glaucoma will remain an important recurring-use market, while corneal and anterior-segment imaging will benefit from premium cataract and refractive workflows.

Specialty ophthalmology clinics will continue to represent the largest end-user segment. However, one of the most disruptive growth opportunities lies outside traditional ophthalmology. Automated retinal cameras and AI-assisted interpretation are making it possible to perform diabetic eye screening in primary care, endocrinology, community health and other distributed settings.

Regional opportunity will remain led by the South, which is projected to grow from approximately USD 0.32 billion in 2025 to USD 0.93 billion by 2035. The West is expected to be the fastest-growing region, increasing from approximately USD 0.25 billion to USD 0.81 billion. The Northeast will remain highly influential in premium adoption and clinical research, while the Midwest will provide a durable installed base and replacement market.

At the state level, California, Texas, Florida and New York represent the most strategically important markets because of their combination of population size, specialist infrastructure and disease burden. Massachusetts, Pennsylvania, New Jersey, North Carolina, Georgia, Arizona, Illinois, Ohio, Michigan, Washington and Minnesota also represent attractive high-value opportunities.

For manufacturers, the central competitive question through 2035 will not simply be which company provides the clearest image. Buyers will increasingly ask whether a system improves the entire clinical workflow: Can less-specialized staff acquire consistent images? Can one device replace several diagnostic stations? Can physicians compare years of historical data efficiently? Can the images be shared across facilities? Can AI prioritize abnormal examinations? Can the system reduce repeat testing and improve patient throughput?

For investors and strategic planners, the highest-value opportunities will therefore occur at the intersection of advanced imaging hardware, automation, diagnostic software and scalable clinical workflow.

The U.S. market remains attractive because ophthalmic imaging is becoming more clinically indispensable at the same time that its deployment is becoming more distributed. Companies capable of combining superior image acquisition with data interoperability, workflow economics, physician trust and measurable clinical utility are positioned to capture the largest share of the market’s projected USD 1.77 billion of incremental value creation between 2025 and 2035.

 

TABLE OF CONTENT

1. U.S. Ophthalmic Imaging Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Ophthalmic Imaging Device Manufacturers
1.6.2. Optical Component, Sensor and Imaging-Software Suppliers
1.6.3. Hospitals, Academic Eye Centers and Integrated Health Systems
1.6.4. Ophthalmology Specialty Clinics and Multi-Site Group Practices
1.6.5. Optometry Practices, Retail Eye-Care Networks and Ambulatory Centers
1.6.6. Distributors, Group Purchasing Organizations and Specialty Dealers
1.6.7. Payers, FDA, CMS and Clinical Decision-Makers

What this section provides: This section defines the market boundary, study scope, methodology, assumptions and stakeholder ecosystem so clients understand how the U.S. ophthalmic imaging devices market is measured, validated and differentiated from the broader ophthalmic equipment market.

2. U.S. Ophthalmic Imaging Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. High-Growth Opportunity Areas
2.7.1. Swept-Source OCT Expansion
2.7.2. OCT Angiography Adoption
2.7.3. Ultra-Widefield Retinal Imaging
2.7.4. AI-Enabled Retinal Screening
2.7.5. Multimodal Ophthalmic Imaging Platforms
2.7.6. Portable and Distributed Eye-Imaging Systems

What this section provides: This section gives decision-makers a concise view of market size, growth trajectory, high-value imaging technologies, competitive intensity, major clinical demand pools and priority investment opportunities.

3. U.S. Ophthalmic Imaging Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising Prevalence of Diabetic Retinopathy and Retinal Disorders
3.1.2. Increasing Age-Related Macular Degeneration Burden
3.1.3. Growing Glaucoma Diagnosis and Longitudinal Monitoring Requirements
3.1.4. Expansion of OCT and Multimodal Imaging in Routine Ophthalmology
3.1.5. Aging U.S. Population and Increasing Ophthalmic Disease Burden
3.1.6. Growth of AI-Enabled Diabetic Retinal Screening
3.1.7. Ophthalmology Practice Consolidation and Diagnostic Infrastructure Expansion
3.2. Restraints and Their Impact Analysis
3.2.1. High Capital Cost of Premium Ophthalmic Imaging Platforms
3.2.2. Reimbursement Pressure and Diagnostic-Test Utilization Scrutiny
3.2.3. Long Replacement Cycles for Installed Imaging Equipment
3.2.4. Ophthalmologist and Ophthalmic Technician Workforce Constraints
3.2.5. Data Interoperability and Vendor-Lock-In Challenges
3.3. Opportunities and Their Impact Analysis
3.3.1. Swept-Source OCT Upgrade Cycle
3.3.2. OCT Angiography Penetration
3.3.3. Ultra-Widefield Imaging Expansion
3.3.4. Autonomous AI-Based Diabetic Eye Screening
3.3.5. Primary Care and Endocrinology-Based Retinal Imaging
3.3.6. Portable and Handheld Ophthalmic Imaging
3.3.7. Multimodal Imaging Platform Consolidation
3.3.8. Cloud-Based Image Management and Teleophthalmology
3.4. Challenges and Their Impact Analysis
3.4.1. Image Standardization Across Different Manufacturers
3.4.2. Integration with Ophthalmology EHR and PACS Infrastructure
3.4.3. Clinical Validation of AI Algorithms Across Diverse Populations
3.4.4. Capital Budget Prioritization in Independent Eye-Care Practices
3.4.5. Cybersecurity and Patient Image-Data Management
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Ophthalmic Imaging Clinical Workflow Economics Analysis
3.7. Ophthalmology Capital Procurement Behavior Analysis
3.8. Equipment Replacement Cycle and Installed-Base Analysis

What this section provides: This section evaluates the clinical, technological, economic and operational forces shaping imaging demand and identifies where market growth can accelerate or encounter adoption barriers through 2035.

4. U.S. Ophthalmic Imaging Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Impact of Digitalization and Connected Ophthalmology
4.6. Ophthalmic Imaging Application & Innovation Landscape
4.7. FDA Regulatory Framework Analysis
4.7.1. Ophthalmic Imaging Device Classification
4.7.2. 510(k) Clearance Pathways
4.7.3. AI/Software as a Medical Device Considerations
4.7.4. Autonomous Diagnostic AI Regulatory Landscape
4.8. CMS Reimbursement and Coverage Landscape
4.8.1. OCT Reimbursement Environment
4.8.2. Fundus Photography Reimbursement Environment
4.8.3. Ophthalmic Ultrasound Reimbursement Environment
4.8.4. Diabetic Retinal Screening Reimbursement Considerations
4.9. Import/Export Restrictions & Tariff Impact
4.10. Government Initiatives and Vision-Health Programs
4.11. Impact of Escalating Geopolitical Tensions
4.12. Ophthalmology Value Analysis and Capital Purchase Decision Framework
4.13. Image Interoperability, Cybersecurity and Data-Governance Landscape

What this section provides: This section gives clients a comprehensive view of the regulatory, reimbursement, pricing, supply-chain, technology, interoperability and procurement environment affecting ophthalmic imaging equipment commercialization in the United States.

5. U.S. Ophthalmic Imaging Devices Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)
5.1.2. Optical Coherence Tomography and OCT Angiography Systems
5.1.2.1. Spectral-Domain OCT Systems
5.1.2.2. Swept-Source OCT Systems
5.1.2.3. OCT Angiography Systems
5.1.2.4. Anterior-Segment OCT Systems
5.1.2.5. Handheld and Portable OCT Systems
5.1.3. Fundus Cameras and Digital Retinal Imaging Systems
5.1.3.1. Mydriatic Fundus Cameras
5.1.3.2. Non-Mydriatic Fundus Cameras
5.1.3.3. Portable and Handheld Fundus Cameras
5.1.3.4. Automated/Robotic Retinal Cameras
5.1.4. Ultra-Widefield Retinal Imaging Systems
5.1.4.1. Scanning Laser Ophthalmoscopy-Based Systems
5.1.4.2. Multimodal Ultra-Widefield Systems
5.1.4.3. Ultra-Widefield Systems with Integrated OCT
5.1.5. Ophthalmic Ultrasound Imaging Systems
5.1.5.1. A-Scan Systems
5.1.5.2. B-Scan Systems
5.1.5.3. Ultrasound Biomicroscopy Systems
5.1.5.4. Combined Ophthalmic Ultrasound Platforms
5.1.6. Corneal, Anterior-Segment and Specialty Imaging Systems
5.1.6.1. Corneal Topography Systems
5.1.6.2. Corneal Tomography Systems
5.1.6.3. Specular Microscopes
5.1.6.4. Digital Slit-Lamp Imaging Systems
5.1.6.5. Specialty Multimodal Anterior-Segment Imaging Systems

What this section provides: This section identifies which ophthalmic imaging product categories are expected to contribute the largest revenue pools, strongest replacement demand and fastest technology-driven growth through 2035.

6. U.S. Ophthalmic Imaging Devices Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Retinal Disorders
6.1.2.1. Age-Related Macular Degeneration
6.1.2.2. Diabetic Retinopathy and Diabetic Macular Edema
6.1.2.3. Retinal Vein Occlusion
6.1.2.4. Retinal Tears and Detachment
6.1.2.5. Geographic Atrophy
6.1.2.6. Inherited Retinal Diseases
6.1.3. Glaucoma
6.1.3.1. Primary Open-Angle Glaucoma
6.1.3.2. Angle-Closure Glaucoma
6.1.3.3. Glaucoma Suspect Monitoring
6.1.3.4. Optic Nerve and RNFL Progression Monitoring
6.1.4. Cataract and Preoperative Ocular Assessment
6.1.4.1. Pre-Cataract Surgery Retinal Evaluation
6.1.4.2. Macular Pathology Screening
6.1.4.3. Anterior-Segment Assessment
6.1.4.4. Premium IOL Candidate Evaluation
6.1.5. Corneal and Refractive Disorders
6.1.5.1. Keratoconus
6.1.5.2. Corneal Dystrophies and Degeneration
6.1.5.3. Refractive Surgery Screening
6.1.5.4. Corneal Transplant Evaluation
6.1.5.5. Specialty Contact Lens Assessment
6.1.6. Other Ophthalmic Applications
6.1.6.1. Uveitis and Ocular Inflammation
6.1.6.2. Neuro-Ophthalmology
6.1.6.3. Pediatric Ophthalmology
6.1.6.4. Ocular Oncology
6.1.6.5. Ocular Trauma

What this section provides: This section quantifies imaging demand by disease and clinical use case, helping clients identify applications with high patient volumes, repeat-imaging intensity, treatment-monitoring requirements and technology-adoption potential.

7. U.S. Ophthalmic Imaging Devices Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Ophthalmology Specialty Clinics and Group Practices
7.1.2.1. Retina Practices
7.1.2.2. Glaucoma Practices
7.1.2.3. Comprehensive Ophthalmology Practices
7.1.2.4. Cornea and Refractive Surgery Practices
7.1.2.5. Multi-Site Ophthalmology Networks
7.1.3. Hospitals and Academic Eye Centers
7.1.3.1. Academic Medical Centers
7.1.3.2. Hospital-Based Ophthalmology Departments
7.1.3.3. Specialty Eye Hospitals
7.1.3.4. Clinical Research and Trial Centers
7.1.4. Optometry Practices and Retail Eye-Care Networks
7.1.4.1. Independent Optometry Practices
7.1.4.2. Multi-Site Optometry Groups
7.1.4.3. Retail Optical and Vision-Care Networks
7.1.5. Ambulatory Surgery Centers
7.1.5.1. Ophthalmology-Focused ASCs
7.1.5.2. Multi-Specialty ASCs with Ophthalmology Services
7.1.6. Primary Care, Teleophthalmology and Distributed Screening Networks
7.1.6.1. Primary Care Practices
7.1.6.2. Endocrinology and Diabetes Clinics
7.1.6.3. Federally Qualified Health Centers
7.1.6.4. Mobile and Community Screening Programs
7.1.6.5. Teleophthalmology Networks

What this section provides: This section explains which care settings are driving capital purchases, replacement cycles, screening expansion and recurring ophthalmic imaging utilization across the U.S.

8. U.S. Ophthalmic Imaging Devices Market – By Technology Type

8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
8.1.2. Spectral-Domain Optical Coherence Tomography
8.1.2.1. Posterior-Segment SD-OCT
8.1.2.2. Anterior-Segment SD-OCT
8.1.2.3. Integrated OCT Platforms
8.1.3. Swept-Source OCT and OCT Angiography
8.1.3.1. Swept-Source Retinal OCT
8.1.3.2. Widefield Swept-Source OCT
8.1.3.3. OCT Angiography
8.1.3.4. Deep Choroidal Imaging
8.1.4. Scanning Laser Ophthalmoscopy and Ultra-Widefield Imaging
8.1.4.1. Confocal Scanning Laser Ophthalmoscopy
8.1.4.2. Ultra-Widefield Scanning Laser Imaging
8.1.4.3. Multimodal SLO Imaging
8.1.5. Digital Color, Autofluorescence and Angiographic Imaging
8.1.5.1. Digital Color Fundus Imaging
8.1.5.2. Fundus Autofluorescence
8.1.5.3. Fluorescein Angiography
8.1.5.4. Indocyanine Green Angiography
8.1.6. Ultrasound and Anterior-Segment Optical Imaging
8.1.6.1. Ophthalmic A/B-Scan Ultrasound
8.1.6.2. Ultrasound Biomicroscopy
8.1.6.3. Corneal Topography
8.1.6.4. Scheimpflug Tomography
8.1.6.5. Specular Microscopy

What this section provides: This section evaluates the imaging technologies reshaping U.S. eye care and identifies where premium technology migration, installed-base upgrades and emerging imaging capabilities will create new revenue opportunities.

9. U.S. Ophthalmic Imaging Devices Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Direct Ophthalmology Practice and Hospital Procurement
9.1.2.1. Single-Site Capital Purchases
9.1.2.2. Multi-Site Practice Procurement
9.1.2.3. Hospital Capital Equipment Purchases
9.1.3. Integrated Health System and Enterprise Contracts
9.1.3.1. Health System Standardization Contracts
9.1.3.2. Multi-Facility Imaging Platform Contracts
9.1.3.3. Enterprise Software and Imaging Integration Agreements
9.1.4. Group Purchasing Organization Contracts
9.1.4.1. Hospital GPO Procurement
9.1.4.2. Physician Practice Purchasing Networks
9.1.5. Distributor and Specialty Ophthalmic Dealer Sales
9.1.5.1. National Ophthalmic Equipment Distributors
9.1.5.2. Regional Specialty Dealers
9.1.5.3. Refurbished and Secondary Equipment Channels
9.1.6. Distributed Screening and Technology Partnership Procurement
9.1.6.1. Primary Care Screening Programs
9.1.6.2. Retail and Community Screening Networks
9.1.6.3. Teleophthalmology Platform Partnerships
9.1.6.4. AI-Enabled Imaging-as-a-Service Models

What this section provides: This section explains how ophthalmic imaging systems are purchased in the U.S., including direct capital sales, group-practice standardization, IDN procurement, distributor influence and emerging subscription or screening-based deployment models.

10. U.S. Ophthalmic Imaging Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Ophthalmic Disease Burden and Imaging Utilization Analysis
10.1.4. Regional Ophthalmologist, Optometrist and Eye-Care Infrastructure Analysis
10.1.5. Regional Reimbursement and Procurement Dynamics
10.1.6. Regional Capital Equipment Replacement and Technology Adoption Analysis
10.2. West Region
10.2.1. Regional Overview & Trends
10.2.2. West Region Ophthalmic Imaging Key Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3. Northeast Region
10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Ophthalmic Imaging Key Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4. South Region
10.4.1. Regional Overview & Trends
10.4.2. South Region Ophthalmic Imaging Key Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5. Midwest Region
10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Ophthalmic Imaging Key Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional and state-level ophthalmic imaging analysis, helping clients identify priority U.S. geographies, disease-burden hotspots, ophthalmology infrastructure clusters, technology-adoption centers and state-level commercial opportunities.

11. U.S. Ophthalmic Imaging Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players
11.3. Company Profiles
11.3.1. Carl Zeiss Meditec AG
11.3.2. Topcon Healthcare
11.3.3. Heidelberg Engineering GmbH
11.3.4. Optos plc / Nikon Corporation
11.3.5. NIDEK CO., LTD.
11.3.6. Canon Inc.
11.3.7. Haag-Streit Group
11.3.8. OCULUS Optikgeräte GmbH
11.3.9. Visionix / Optovue
11.3.10. Revenio Group / iCare
11.3.11. Kowa Company, Ltd.
11.3.12. Tomey Corporation
11.3.13. Lumibird Medical / Quantel Medical
11.3.14. DGH Technology, Inc.
11.3.15. Escalon Medical Corp. / Sonomed
11.3.16. Optomed Plc
11.3.17. Phoenix Technology Group
11.3.18. Digital Diagnostics Inc.
11.3.19. Eyenuk, Inc.
11.3.20. AEYE Health
11.3.21. RetinAI Medical AG
11.3.22. Alcon Inc.
11.3.23. Ziemer Ophthalmic Systems AG
11.3.24. Konan Medical USA, Inc.
11.3.25. Remidio Innovative Solutions
11.4. Competitive Benchmarking by Product Portfolio
11.5. Competitive Benchmarking by Imaging Technology
11.6. U.S. Installed-Base and Replacement Positioning
11.7. AI and Imaging-Software Competitive Landscape
11.8. Partnerships, Acquisitions and Strategic Alliances
11.9. FDA Clearance and Product Launch Benchmarking, 2021–2026

Note: Each company profile will include company overview, ophthalmic imaging portfolio, U.S. market strategy, technology positioning, financial positioning where available, FDA/regulatory developments, partnerships, product launches and recent strategic developments.

What this section provides: This section gives clients competitor benchmarking, market-share visibility, portfolio positioning, installed-base intelligence, technology differentiation and strategic insight into leading ophthalmic imaging companies.

12. U.S. Ophthalmic Imaging Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Swept-Source and Next-Generation OCT
12.2.2. AI-Assisted and Autonomous Retinal Imaging
12.2.3. Ultra-Widefield and Multimodal Imaging
12.2.4. Portable and Handheld Ophthalmic Imaging
12.2.5. Cloud-Based Image Management and Interoperability
12.2.6. Quantitative Imaging Biomarkers and Oculomics
12.3. Emerging Business Trends
12.3.1. Imaging-as-a-Service Models
12.3.2. Ophthalmology Practice Consolidation
12.3.3. Distributed Diabetic Retinal Screening
12.3.4. Enterprise Imaging Standardization
12.3.5. AI-Enabled Workflow Automation
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
12.6. Technology Adoption Curve, 2026–2035
12.7. Replacement-Cycle Opportunity Analysis
12.8. White-Space Opportunity Assessment

What this section provides: This section prepares clients for future imaging technology shifts, adoption scenarios, changing business models and investment opportunities expected to reshape the U.S. ophthalmic imaging devices market through 2035.

13. U.S. Ophthalmic Imaging Devices Market: Strategic Recommendations

13.1. Recommendations for Ophthalmic Imaging Device Manufacturers
13.2. Recommendations for Hospitals and Academic Eye Centers
13.3. Recommendations for Ophthalmology and Optometry Group Practices
13.4. Recommendations for Investors and Private Equity Firms
13.5. Recommendations for Distributors and Channel Partners
13.6. Recommendations for AI Imaging and Digital Health Companies
13.7. Recommendations for New Entrants and Startups
13.8. Go-to-Market Strategy Considerations
13.9. Product Positioning and Portfolio Expansion Guidance
13.10. State and Regional Market Prioritization Strategy
13.11. Clinical Evidence and KOL Engagement Strategy
13.12. Pricing, Service Contract and Lifecycle Revenue Strategy

What this section provides: This section converts market intelligence into actionable recommendations for product strategy, market entry, geographic expansion, channel development, capital-equipment positioning, investment prioritization and competitive differentiation.

14. U.S. Ophthalmic Imaging Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Legal Disclaimer
14.5. Third-Party Data Disclaimer
14.6. Market Modeling and Estimate Limitation

What this section provides: This section clarifies the report’s analytical boundaries, data-use conditions, forecasting limitations, market-estimation assumptions and legal considerations.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Ophthalmic Imaging Devices Market: Market Definition and Scope
TABLE 3: U.S. Ophthalmic Imaging Devices Market: Research Methodology Framework
TABLE 4: U.S. Ophthalmic Imaging Devices Market: Key Assumptions
TABLE 5: U.S. Ophthalmic Imaging Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Ophthalmic Imaging Devices Market: Stakeholder Analysis
TABLE 7: U.S. Ophthalmic Imaging Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Ophthalmic Imaging Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Ophthalmic Imaging Devices Market: Market Attractiveness Index
TABLE 10: U.S. Ophthalmic Imaging Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Ophthalmic Imaging Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Ophthalmic Imaging Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Ophthalmic Imaging Devices Market: High-Growth Opportunity Areas
TABLE 14: U.S. Ophthalmic Imaging Devices Market: Drivers; Impact Analysis
TABLE 15: U.S. Ophthalmic Imaging Devices Market: Restraints; Impact Analysis
TABLE 16: U.S. Ophthalmic Imaging Devices Market: Opportunities; Impact Analysis
TABLE 17: U.S. Ophthalmic Imaging Devices Market: Challenges; Impact Analysis
TABLE 18: U.S. Ophthalmic Imaging Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 19: U.S. Ophthalmic Imaging Devices Market: Ophthalmic Imaging Clinical Workflow Economics Matrix
TABLE 20: U.S. Ophthalmic Imaging Devices Market: Ophthalmology Capital Procurement Behavior Matrix
TABLE 21: U.S. Ophthalmic Imaging Devices Market: Equipment Replacement Cycle and Installed-Base Analysis
TABLE 22: U.S. Ophthalmic Imaging Devices Market: PESTEL Analysis
TABLE 23: U.S. Ophthalmic Imaging Devices Market: Porter’s Five Forces Analysis
TABLE 24: U.S. Ophthalmic Imaging Devices Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 25: U.S. Ophthalmic Imaging Devices Market: Value Chain Analysis
TABLE 26: U.S. Ophthalmic Imaging Devices Market: Supply Chain Analysis
TABLE 27: U.S. Ophthalmic Imaging Devices Market: Digitalization and Connected Ophthalmology Impact
TABLE 28: U.S. Ophthalmic Imaging Devices Market: Ophthalmic Imaging Application & Innovation Landscape
TABLE 29: U.S. Ophthalmic Imaging Devices Market: FDA Regulatory Framework Analysis
TABLE 30: U.S. Ophthalmic Imaging Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 31: U.S. Ophthalmic Imaging Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 32: U.S. Ophthalmic Imaging Devices Market: Government Initiatives and Vision-Health Programs
TABLE 33: U.S. Ophthalmic Imaging Devices Market: Impact of Escalating Geopolitical Tensions
TABLE 34: U.S. Ophthalmic Imaging Devices Market: Ophthalmology Value Analysis and Capital Purchase Decision Framework
TABLE 35: U.S. Ophthalmic Imaging Devices Market: Image Interoperability, Cybersecurity and Data-Governance Landscape
TABLE 36: U.S. Ophthalmic Imaging Devices Market: Product Category Snapshot, 2025
TABLE 37: Segment Dashboard; Definition and Scope, by Product Category
TABLE 38: U.S. Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 39: U.S. Ophthalmic Imaging Devices Market: Segment Share Analysis, by Product Category, 2025 & 2035 (%)
TABLE 40: U.S. Ophthalmic Imaging Devices Market: Optical Coherence Tomography and OCT Angiography Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 41: U.S. Ophthalmic Imaging Devices Market: Fundus Cameras and Digital Retinal Imaging Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 42: U.S. Ophthalmic Imaging Devices Market: Ultra-Widefield Retinal Imaging Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 43: U.S. Ophthalmic Imaging Devices Market: Ophthalmic Ultrasound Imaging Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 44: U.S. Ophthalmic Imaging Devices Market: Corneal, Anterior-Segment and Specialty Imaging Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 45: U.S. Ophthalmic Imaging Devices Market: Application Snapshot, 2025
TABLE 46: Segment Dashboard; Definition and Scope, by Application
TABLE 47: U.S. Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 48: U.S. Ophthalmic Imaging Devices Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 49: U.S. Ophthalmic Imaging Devices Market: Retinal Disorders Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: U.S. Ophthalmic Imaging Devices Market: Glaucoma Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: U.S. Ophthalmic Imaging Devices Market: Cataract and Preoperative Ocular Assessment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: U.S. Ophthalmic Imaging Devices Market: Corneal and Refractive Disorders Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: U.S. Ophthalmic Imaging Devices Market: Other Ophthalmic Applications Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: U.S. Ophthalmic Imaging Devices Market: End User Snapshot, 2025
TABLE 55: Segment Dashboard; Definition and Scope, by End User
TABLE 56: U.S. Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 57: U.S. Ophthalmic Imaging Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 58: U.S. Ophthalmic Imaging Devices Market: Ophthalmology Specialty Clinics and Group Practices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: U.S. Ophthalmic Imaging Devices Market: Hospitals and Academic Eye Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: U.S. Ophthalmic Imaging Devices Market: Optometry Practices and Retail Eye-Care Networks Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: U.S. Ophthalmic Imaging Devices Market: Ambulatory Surgery Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: U.S. Ophthalmic Imaging Devices Market: Primary Care, Teleophthalmology and Distributed Screening Networks Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: U.S. Ophthalmic Imaging Devices Market: Technology Type Snapshot, 2025
TABLE 64: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 65: U.S. Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 66: U.S. Ophthalmic Imaging Devices Market: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 67: U.S. Ophthalmic Imaging Devices Market: Spectral-Domain Optical Coherence Tomography Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: U.S. Ophthalmic Imaging Devices Market: Swept-Source OCT and OCT Angiography Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: U.S. Ophthalmic Imaging Devices Market: Scanning Laser Ophthalmoscopy and Ultra-Widefield Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 70: U.S. Ophthalmic Imaging Devices Market: Digital Color, Autofluorescence and Angiographic Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 71: U.S. Ophthalmic Imaging Devices Market: Ultrasound and Anterior-Segment Optical Imaging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: U.S. Ophthalmic Imaging Devices Market: Procurement Channel Snapshot, 2025
TABLE 73: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 74: U.S. Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 75: U.S. Ophthalmic Imaging Devices Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 76: U.S. Ophthalmic Imaging Devices Market: Direct Ophthalmology Practice and Hospital Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. Ophthalmic Imaging Devices Market: Integrated Health System and Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: U.S. Ophthalmic Imaging Devices Market: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 79: U.S. Ophthalmic Imaging Devices Market: Distributor and Specialty Ophthalmic Dealer Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 80: U.S. Ophthalmic Imaging Devices Market: Distributed Screening and Technology Partnership Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 81: U.S. Ophthalmic Imaging Devices Market: Regional Snapshot, 2025
TABLE 82: Segment Dashboard; Definition and Scope, by Region
TABLE 83: U.S. Ophthalmic Imaging Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 84: U.S. Ophthalmic Imaging Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 85: U.S. Ophthalmic Imaging Devices Market: Regional Ophthalmic Disease Burden and Imaging Utilization Analysis
TABLE 86: U.S. Ophthalmic Imaging Devices Market: Regional Ophthalmologist, Optometrist and Eye-Care Infrastructure Analysis
TABLE 87: West Region U.S. Ophthalmic Imaging Devices Market: Regional Overview and Trends
TABLE 88: West Region U.S. Ophthalmic Imaging Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 89: West Region U.S. Ophthalmic Imaging Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 90: West Region U.S. Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 91: West Region U.S. Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 92: West Region U.S. Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 93: West Region U.S. Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 94: West Region U.S. Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 95: California Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 96: California Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 97: California Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 98: California Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 99: California Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 100: Washington Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 101: Washington Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 102: Washington Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 103: Washington Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 104: Washington Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 105: Arizona Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 106: Arizona Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 107: Arizona Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 108: Arizona Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 109: Arizona Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 110: Colorado Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 111: Colorado Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 112: Colorado Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 113: Colorado Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 114: Colorado Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 115: Oregon Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 116: Oregon Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 117: Oregon Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 118: Oregon Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 119: Oregon Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 120: Utah Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 121: Utah Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 122: Utah Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 123: Utah Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 124: Utah Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 125: Nevada Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 126: Nevada Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 127: Nevada Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 128: Nevada Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 129: Nevada Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 130: New Mexico Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 131: New Mexico Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 132: New Mexico Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 133: New Mexico Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 134: New Mexico Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 135: Idaho Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 136: Idaho Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 137: Idaho Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 138: Idaho Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 139: Idaho Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 140: Montana Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 141: Montana Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 142: Montana Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 143: Montana Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 144: Montana Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 145: Wyoming Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 146: Wyoming Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 147: Wyoming Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 148: Wyoming Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 149: Wyoming Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 150: Alaska Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 151: Alaska Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 152: Alaska Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 153: Alaska Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 154: Alaska Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 155: Hawaii Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 156: Hawaii Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 157: Hawaii Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 158: Hawaii Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 159: Hawaii Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 160: Northeast Region U.S. Ophthalmic Imaging Devices Market: Regional Overview and Trends
TABLE 161: Northeast Region U.S. Ophthalmic Imaging Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 162: Northeast Region U.S. Ophthalmic Imaging Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 163: Northeast Region U.S. Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 164: Northeast Region U.S. Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 165: Northeast Region U.S. Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 166: Northeast Region U.S. Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 167: Northeast Region U.S. Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 168: New York Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 169: New York Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 170: New York Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 171: New York Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 172: New York Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 173: Massachusetts Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 174: Massachusetts Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 175: Massachusetts Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 176: Massachusetts Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 177: Massachusetts Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 178: New Jersey Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 179: New Jersey Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 180: New Jersey Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 181: New Jersey Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 182: New Jersey Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 183: Pennsylvania Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 184: Pennsylvania Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 185: Pennsylvania Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 186: Pennsylvania Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 187: Pennsylvania Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 188: Connecticut Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 189: Connecticut Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 190: Connecticut Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 191: Connecticut Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 192: Connecticut Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 193: Maine Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 194: Maine Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 195: Maine Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 196: Maine Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 197: Maine Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 198: Vermont Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 199: Vermont Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 200: Vermont Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 201: Vermont Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 202: Vermont Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 203: New Hampshire Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 204: New Hampshire Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 205: New Hampshire Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 206: New Hampshire Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 207: New Hampshire Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 208: Rhode Island Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 209: Rhode Island Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 210: Rhode Island Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 211: Rhode Island Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 212: Rhode Island Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 213: Delaware Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 214: Delaware Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 215: Delaware Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 216: Delaware Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 217: Delaware Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 218: South Region U.S. Ophthalmic Imaging Devices Market: Regional Overview and Trends
TABLE 219: South Region U.S. Ophthalmic Imaging Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 220: South Region U.S. Ophthalmic Imaging Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 221: South Region U.S. Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 222: South Region U.S. Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 223: South Region U.S. Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 224: South Region U.S. Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 225: South Region U.S. Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 226: Texas Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 227: Texas Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 228: Texas Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 229: Texas Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 230: Texas Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 231: Florida Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 232: Florida Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 233: Florida Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 234: Florida Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 235: Florida Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 236: Georgia Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 237: Georgia Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 238: Georgia Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 239: Georgia Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 240: Georgia Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 241: North Carolina Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 242: North Carolina Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 243: North Carolina Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 244: North Carolina Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 245: North Carolina Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 246: Tennessee Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 247: Tennessee Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 248: Tennessee Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 249: Tennessee Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 250: Tennessee Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 251: South Carolina Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 252: South Carolina Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 253: South Carolina Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 254: South Carolina Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 255: South Carolina Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 256: Alabama Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 257: Alabama Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 258: Alabama Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 259: Alabama Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 260: Alabama Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 261: Mississippi Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 262: Mississippi Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 263: Mississippi Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 264: Mississippi Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 265: Mississippi Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 266: Louisiana Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 267: Louisiana Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 268: Louisiana Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 269: Louisiana Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 270: Louisiana Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 271: Arkansas Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 272: Arkansas Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 273: Arkansas Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 274: Arkansas Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 275: Arkansas Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 276: Kentucky Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 277: Kentucky Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 278: Kentucky Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 279: Kentucky Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 280: Kentucky Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 281: Oklahoma Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 282: Oklahoma Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 283: Oklahoma Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 284: Oklahoma Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 285: Oklahoma Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 286: Virginia Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 287: Virginia Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 288: Virginia Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 289: Virginia Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 290: Virginia Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 291: Maryland Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 292: Maryland Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 293: Maryland Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 294: Maryland Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 295: Maryland Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 296: West Virginia Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 297: West Virginia Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 298: West Virginia Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 299: West Virginia Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 300: West Virginia Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 301: Midwest Region U.S. Ophthalmic Imaging Devices Market: Regional Overview and Trends
TABLE 302: Midwest Region U.S. Ophthalmic Imaging Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 303: Midwest Region U.S. Ophthalmic Imaging Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 304: Midwest Region U.S. Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 305: Midwest Region U.S. Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 306: Midwest Region U.S. Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 307: Midwest Region U.S. Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 308: Midwest Region U.S. Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 309: Illinois Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 310: Illinois Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 311: Illinois Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 312: Illinois Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 313: Illinois Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 314: Ohio Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 315: Ohio Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 316: Ohio Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 317: Ohio Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 318: Ohio Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 319: Michigan Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 320: Michigan Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 321: Michigan Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 322: Michigan Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 323: Michigan Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 324: Minnesota Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 325: Minnesota Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 326: Minnesota Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 327: Minnesota Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 328: Minnesota Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 329: Indiana Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 330: Indiana Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 331: Indiana Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 332: Indiana Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 333: Indiana Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 334: Wisconsin Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 335: Wisconsin Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 336: Wisconsin Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 337: Wisconsin Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 338: Wisconsin Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 339: Missouri Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 340: Missouri Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 341: Missouri Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 342: Missouri Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 343: Missouri Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 344: Iowa Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 345: Iowa Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 346: Iowa Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 347: Iowa Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 348: Iowa Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 349: Kansas Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 350: Kansas Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 351: Kansas Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 352: Kansas Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 353: Kansas Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 354: Nebraska Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 355: Nebraska Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 356: Nebraska Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 357: Nebraska Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 358: Nebraska Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 359: North Dakota Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 360: North Dakota Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 361: North Dakota Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 362: North Dakota Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 363: North Dakota Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 364: South Dakota Ophthalmic Imaging Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 365: South Dakota Ophthalmic Imaging Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 366: South Dakota Ophthalmic Imaging Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 367: South Dakota Ophthalmic Imaging Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 368: South Dakota Ophthalmic Imaging Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 369: U.S. Ophthalmic Imaging Devices Market: Competitive Landscape Snapshot, 2025
TABLE 370: U.S. Ophthalmic Imaging Devices Market: Key Company Market Share Analysis, 2025
TABLE 371: U.S. Ophthalmic Imaging Devices Market: Company Positioning Matrix
TABLE 372: U.S. Ophthalmic Imaging Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 373: U.S. Ophthalmic Imaging Devices Market: Imaging Technology Benchmarking of Key Players
TABLE 374: U.S. Ophthalmic Imaging Devices Market: U.S. Installed-Base and Replacement Positioning
TABLE 375: U.S. Ophthalmic Imaging Devices Market: AI and Imaging-Software Competitive Landscape
TABLE 376: U.S. Ophthalmic Imaging Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 377: U.S. Ophthalmic Imaging Devices Market: FDA Clearance and Product Launch Benchmarking, 2021–2026
TABLE 378: Carl Zeiss Meditec AG: Company Profile
TABLE 379: Topcon Healthcare: Company Profile
TABLE 380: Heidelberg Engineering GmbH: Company Profile
TABLE 381: Optos plc / Nikon Corporation: Company Profile
TABLE 382: NIDEK CO., LTD.: Company Profile
TABLE 383: Canon Inc.: Company Profile
TABLE 384: Haag-Streit Group: Company Profile
TABLE 385: OCULUS Optikgeräte GmbH: Company Profile
TABLE 386: Visionix / Optovue: Company Profile
TABLE 387: Revenio Group / iCare: Company Profile
TABLE 388: Kowa Company, Ltd.: Company Profile
TABLE 389: Tomey Corporation: Company Profile
TABLE 390: Lumibird Medical / Quantel Medical: Company Profile
TABLE 391: DGH Technology, Inc.: Company Profile
TABLE 392: Escalon Medical Corp. / Sonomed: Company Profile
TABLE 393: Optomed Plc: Company Profile
TABLE 394: Phoenix Technology Group: Company Profile
TABLE 395: Digital Diagnostics Inc.: Company Profile
TABLE 396: Eyenuk, Inc.: Company Profile
TABLE 397: AEYE Health: Company Profile
TABLE 398: RetinAI Medical AG: Company Profile
TABLE 399: Alcon Inc.: Company Profile
TABLE 400: Ziemer Ophthalmic Systems AG: Company Profile
TABLE 401: Konan Medical USA, Inc.: Company Profile
TABLE 402: Remidio Innovative Solutions: Company Profile
TABLE 403: U.S. Ophthalmic Imaging Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 404: U.S. Ophthalmic Imaging Devices Market: Disruptive Technologies Impact Matrix
TABLE 405: U.S. Ophthalmic Imaging Devices Market: Emerging Business Trends
TABLE 406: U.S. Ophthalmic Imaging Devices Market: Business Opportunities for Startups and Existing Players
TABLE 407: U.S. Ophthalmic Imaging Devices Market: Investment Prioritization Matrix
TABLE 408: U.S. Ophthalmic Imaging Devices Market: Technology Adoption Curve, 2026–2035
TABLE 409: U.S. Ophthalmic Imaging Devices Market: Replacement-Cycle Opportunity Analysis
TABLE 410: U.S. Ophthalmic Imaging Devices Market: White-Space Opportunity Assessment
TABLE 411: U.S. Ophthalmic Imaging Devices Market: Strategic Recommendations for Ophthalmic Imaging Device Manufacturers
TABLE 412: U.S. Ophthalmic Imaging Devices Market: Strategic Recommendations for Hospitals and Academic Eye Centers
TABLE 413: U.S. Ophthalmic Imaging Devices Market: Strategic Recommendations for Ophthalmology and Optometry Group Practices
TABLE 414: U.S. Ophthalmic Imaging Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 415: U.S. Ophthalmic Imaging Devices Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 416: U.S. Ophthalmic Imaging Devices Market: Strategic Recommendations for AI Imaging and Digital Health Companies
TABLE 417: U.S. Ophthalmic Imaging Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 418: U.S. Ophthalmic Imaging Devices Market: Go-to-Market Strategy Considerations
TABLE 419: U.S. Ophthalmic Imaging Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 420: U.S. Ophthalmic Imaging Devices Market: State and Regional Market Prioritization Strategy
TABLE 421: U.S. Ophthalmic Imaging Devices Market: Clinical Evidence and KOL Engagement Strategy
TABLE 422: U.S. Ophthalmic Imaging Devices Market: Pricing, Service Contract and Lifecycle Revenue Strategy
TABLE 423: U.S. Ophthalmic Imaging Devices Market: Scope Limitation
TABLE 424: U.S. Ophthalmic Imaging Devices Market: Data Use Limitation
TABLE 425: U.S. Ophthalmic Imaging Devices Market: Forecasting Limitation
TABLE 426: U.S. Ophthalmic Imaging Devices Market: Legal Disclaimer
TABLE 427: U.S. Ophthalmic Imaging Devices Market: Third-Party Data Disclaimer
TABLE 428: U.S. Ophthalmic Imaging Devices Market: Market Modeling and Estimate Limitation

List of Figures

FIGURE 1: U.S. Ophthalmic Imaging Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: Supply Chain Analysis
FIGURE 5: PESTEL Analysis
FIGURE 6: Porter’s Five Forces Analysis
FIGURE 7: Market Attractiveness Analysis
FIGURE 8: Market Dynamics
FIGURE 9: Innovation & Patent Landscape, 2021–2025
FIGURE 10: Ophthalmic Imaging Clinical Workflow Economics Framework
FIGURE 11: Ophthalmology Capital Procurement Decision Framework
FIGURE 12: Equipment Replacement Cycle and Installed-Base Framework
FIGURE 13: U.S. Ophthalmic Imaging Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 14: U.S. Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 15: U.S. Ophthalmic Imaging Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 16: Product Category Segment Market Share Analysis, 2025 & 2035
FIGURE 17: Product Category Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 18: Optical Coherence Tomography and OCT Angiography Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 19: Fundus Cameras and Digital Retinal Imaging Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 20: Ultra-Widefield Retinal Imaging Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Ophthalmic Ultrasound Imaging Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Corneal, Anterior-Segment and Specialty Imaging Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 24: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Retinal Disorders Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Glaucoma Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Cataract and Preoperative Ocular Assessment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Corneal and Refractive Disorders Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Other Ophthalmic Applications Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 31: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Ophthalmology Specialty Clinics and Group Practices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Hospitals and Academic Eye Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Optometry Practices and Retail Eye-Care Networks Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Ambulatory Surgery Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Primary Care, Teleophthalmology and Distributed Screening Networks Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 38: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Spectral-Domain Optical Coherence Tomography Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Swept-Source OCT and OCT Angiography Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Scanning Laser Ophthalmoscopy and Ultra-Widefield Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Digital Color, Autofluorescence and Angiographic Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Ultrasound and Anterior-Segment Optical Imaging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 45: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Direct Ophthalmology Practice and Hospital Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Integrated Health System and Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Distributor and Specialty Ophthalmic Dealer Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Distributed Screening and Technology Partnership Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 52: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: West Region U.S. Ophthalmic Imaging Devices Market Share and Leading Players, 2025
FIGURE 54: West Region Market Share Analysis by State, 2025
FIGURE 55: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: California Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: Washington Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: Arizona Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: Colorado Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Oregon Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: Utah Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: Nevada Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: New Mexico Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Idaho Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Montana Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Wyoming Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Alaska Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Hawaii Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Northeast Region U.S. Ophthalmic Imaging Devices Market Share and Leading Players, 2025
FIGURE 70: Northeast Region Market Share Analysis by State, 2025
FIGURE 71: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: New York Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: Massachusetts Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: New Jersey Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: Pennsylvania Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Connecticut Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: Maine Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: Vermont Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: New Hampshire Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Rhode Island Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: Delaware Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: South Region U.S. Ophthalmic Imaging Devices Market Share and Leading Players, 2025
FIGURE 83: South Region Market Share Analysis by State, 2025
FIGURE 84: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: Texas Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Florida Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: Georgia Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: North Carolina Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: Tennessee Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: South Carolina Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Alabama Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Mississippi Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Louisiana Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Arkansas Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Kentucky Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Oklahoma Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Virginia Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Maryland Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: West Virginia Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Midwest Region U.S. Ophthalmic Imaging Devices Market Share and Leading Players, 2025
FIGURE 101: Midwest Region Market Share Analysis by State, 2025
FIGURE 102: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Illinois Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Ohio Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Michigan Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Minnesota Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Indiana Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Wisconsin Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Missouri Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Iowa Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Kansas Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Nebraska Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: North Dakota Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: South Dakota Ophthalmic Imaging Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 116: Company Positioning Matrix
FIGURE 117: Key Player Product Portfolio Benchmarking
FIGURE 118: Key Player Imaging Technology Benchmarking
FIGURE 119: U.S. Installed-Base and Replacement Positioning
FIGURE 120: AI and Imaging-Software Competitive Landscape
FIGURE 121: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 122: Ophthalmic Imaging Innovation Roadmap
FIGURE 123: Swept-Source OCT Adoption Roadmap
FIGURE 124: AI-Enabled Retinal Imaging Opportunity Map
FIGURE 125: Ultra-Widefield and Multimodal Imaging Growth Roadmap
FIGURE 126: Future Market Scenario Analysis, 2026–2035
FIGURE 127: Disruptive Technologies Impact Matrix
FIGURE 128: Emerging Business Trends Matrix
FIGURE 129: Investment Prioritization Matrix
FIGURE 130: Technology Adoption Curve, 2026–2035
FIGURE 131: White-Space Opportunity Map
FIGURE 132: Strategic Growth Roadmap for U.S. Ophthalmic Imaging Device Companies
FIGURE 133: Go-to-Market Strategy Framework
FIGURE 134: Product Positioning and Portfolio Expansion Framework
FIGURE 135: State and Regional Market Prioritization Framework
FIGURE 136: Report Scope and Disclaimer Framework